ERBB2 and breast cancer: This includes luminal A (ER+ and/or PR+, and HER2-), luminal B (ER+ and/or PR+, and HER2+), HER2-enriched (ER- and PR-, and HER2+), and basal-like or triple-negative (ER-, PR-, and HER2-) BC [12].